Outcomes of adding induction chemotherapy to concurrent chemo-radiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

The objective study was to examine whether adding induction chemotherapy to concurrent chemo-radiotherapy improved survival in stage III nasopharyngeal carcinoma (NPC) patients, especially in low-risk patients at stage T3N0-1.
Dove Medical Press